The concept of “mixed pain” simultaneously highlights the benefit of integration of emerging advances in basic science (in particular, physiologic mechanisms) with advances in clinical care ...

Case study: EMS respond to a 911 call for an elderly woman in respiratory distress. She is a 71-year-old female with a past medical history significant for chronic obstructive pulmonary disease (COPD) ...

Opioids like morphine are widely used in medical practice due to their powerful pain-relieving effects, yet they carry the risk of serious adverse effects such as respiratory depression and drug ...

A new understanding of how aspirin stimulates the immune system to reduce the metastasis of some early cancers could lead to its targeted use to prevent some cancers from spreading, researchers report ...

FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve clinical outcomes and QOL. Pain is one of the most prevalent reasons patients ...

An international research team headed by scientists at the University of Cambridge has uncovered a mechanism that may underpin how aspirin could reduce the metastasis of some cancers by preventing an ...

Aspirin, acetylsalicylic acid, is classified among the nonsteroidal anti-inflammatory drugs. These agents reduce the signs and symptoms of inflammation and exhibit a broad range of pharmacological ...

The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time in over two decades that the agency has approved a non-opioid pain drug ...

John Seymour, MBBS, FRACP, PhD, explains the mechanism of action of BCL-2 inhibitors like venetoclax. John Seymour, MBBS, FRACP, PhD, director of hematology at the Peter MacCallum Cancer Center and ...

SHANGHAI--(BUSINESS WIRE)--#acutepain--Xgene Pharmaceutical announced additional insights into the positive results of a multiple-center, placebo-controlled, dose-ranging Phase 2b study (registration ...